Active Ingredient(s): Nitisinone
FDA Approved: * July 26, 2017
Pharm Company: * CYCLE PHARMS LTD
Category: Genetic Disorders

Nitisinone, sold under the brand name Orfadin among others, is a medication used to slow the effects of hereditary tyrosinemia type 1 (HT-1). Contents 1 Uses 2 Adverse effects 3 Mechanism of action 4 History 5 Research 6 References 7 External links Uses Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) in patients from all ages, in combination with dietary restriction of tyrosine and phenylalanine.[medical citation needed] Since its first use for this ind... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nityr 10 mg Oral Tablet
NDC: 70709-000
Cycle Pharmaceuticals Ltd.
Nityr 2 mg Oral Tablet
NDC: 70709-002
Cycle Pharmaceuticals Ltd.
Nityr 5 mg Oral Tablet
NDC: 70709-005
Cycle Pharmaceuticals Ltd.

Related Brands

Drugs with the same active ingredients